Celgene Corp. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,450
2,000
1,602
1,999
2,940
4,046
Depreciation, Depletion & Amortization
374
374
402
505
471
635
Other Funds
56
225
301
148
-
693
Funds from Operations
2,222
2,691
2,540
3,431
3,075
5,406
Changes in Working Capital
4
115
56
546
2,171
235
Net Operating Cash Flow
2,226
2,806
2,484
3,976
5,246
5,171
Capital Expenditures
139
175
286
236
279
Purchase/Sale of Investments
388
553
1,730
765
2,585
Net Investing Cash Flow
529
1,438
6,259
1,002
2,891
Issuance/Reduction of Debt, Net
1,714
2,025
7,298
-
1,564
Net Financing Cash Flow
554
417
4,585
1,646
1,584
Net Change in Cash
1,144
887
759
1,290
843
Free Cash Flow
2,106
2,656
2,198
3,740
4,967
Deferred Taxes & Investment Tax Credit
247
272
33
344
1,330
32
Net Assets from Acquisitions
-
710
7,695
-
-
Change in Capital Stock
2,212
2,668
3,014
1,793
3,148
Exchange Rate Effect
-
64
51
39
72
About Celgene
View Profile
